2009
DOI: 10.1177/1938640008330770
|View full text |Cite
|
Sign up to set email alerts
|

Symmetry of Sensory Loss in Developing Diabetic Sensory Polyneuropathy

Abstract: The medical literature presents diabetic sensory polyneuropathy (DSPN) as an axonal length-dependent symmetric pathology producing a stocking-like pattern of anesthesia in the lower extremities. This has been based on anecdotal reports. Objective research has shown that damage may not occur in a purely length-dependent manner. A stocking distribution of sensory loss is atypical, and plantar sensory loss predominates. A single-blinded, age-matched, control/experimental study was performed of the symmetry of ner… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 27 publications
1
3
0
Order By: Relevance
“…Our data are consistent with those of Weintrob et al [36] who reported that unmyelinated C small fibers are more vulnerable than myelinated Ad small fibers in diabetes [12,36]. Furthermore, previous studies have reported that diabetic small-fiber neuropathy is length dependent [37,38]. Longer nerves are more easily destroyed, so the distal nerves in the lower extremities are more vulnerable than those in the hands.…”
Section: Discussionsupporting
confidence: 92%
“…Our data are consistent with those of Weintrob et al [36] who reported that unmyelinated C small fibers are more vulnerable than myelinated Ad small fibers in diabetes [12,36]. Furthermore, previous studies have reported that diabetic small-fiber neuropathy is length dependent [37,38]. Longer nerves are more easily destroyed, so the distal nerves in the lower extremities are more vulnerable than those in the hands.…”
Section: Discussionsupporting
confidence: 92%
“…• For the hypothesized nerve enlargement in DSPN by strong objective level I evidence; 47,48 • Asymmetry and variability of global foot sensibility, Oxford EBM level II-1; 45,52 • High perineural tissue pressures within inflexible anatomic tunnel structures, and relief of pressure by ND, Level II-1; 35 • Subjective relief of DSPN pain, recovery of lost sensibility, and improved symptom scores, Level II-2 and II-3 evidence; 36,42 • Improved objective outcomes, including balance, perineural pressure, NCV, ulcer occurrence, prolonged protection from recurrence, and amputation risk, are supported by Level II-1 to Level II-2 evidence.…”
Section: Resultsmentioning
confidence: 99%
“…• For the hypothesized nerve enlargement in DSPN by strong objective level I evidence; 47,48 • Asymmetry and variability of global foot sensibility, Oxford EBM level II-1; 45,52 • High perineural tissue pressures within inflexible anatomic tunnel structures, and relief of pressure by ND, Level II-1;…”
Section: Resultsmentioning
confidence: 99%
“…Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease damaging carbohydrate, fat and protein metabolism due to the absence of insulin secretion or decrease in insulin sensitivity of tissues, requiring continuous medical care 1,2 . Peripheral diabetic neuropathy (PDN) is one of the most common complications of diabetes characterized by a wide spectrum of problems, ranging from autonomous cardiovascular changes to diabetic foot ulcer, which decrease the pa-tient quality of life [3][4][5] . In addition, in individuals with peripheral neuropathy, significant disorders of tactile sense, vibration, lower extremity proprioception and kinesthesia sense can be observed 6 .…”
Section: Introductionmentioning
confidence: 99%